Ahrén, B. “Incretin Therapy for Type 2 Diabetes: GLP-1 Receptor Agonists and DPP-4 Inhibitors”. International Diabetes Nursing, vol. 10, no. 1, Feb. 2013, pp. 31-36, doi:10.1002/edn.221.